TIDMIHC
RNS Number : 3218C
Inspiration Healthcare Group PLC
12 June 2023
Inspiration Healthcare Group plc
("Inspiration Healthcare", the "Company" or the "Group")
Appointment of Chief Financial Officer
and
Grant of Options
Inspiration Healthcare Group plc (AIM: IHC), the global medical
technology company pioneering best-in class, specialist neonatal
intensive care medical devices, announces the appointment of Alan
Olby ACA as Chief Financial Officer and a Director of the Company,
effective immediately.
Alan is an experienced and commercially focused healthcare CFO,
with extensive international and operational experience within
fast-growing listed and private healthcare companies. He spent 16
years at Sinclair Pharma, of which 12 years were as CFO and a
member of the executive leadership team and he was instrumental in
transforming the company into a fast growth global aesthetics
business, which was sold to Huadong Medicine Co Ltd for GBP165
million in 2018.
During his tenure he oversaw several successful capital raises,
and a number of strategic M&A transactions, including the
disposal of the non-core business to Alliance Pharma for GBP132
million in 2015. Prior to Sinclair Pharma, Alan was Group Financial
Controller of Xenova Group plc and KS Biomedix plc.
Neil Campbell, Chief Executive Officer of Inspiration Healthcare
said: "We are delighted to have someone of Alan's calibre join
Inspiration Healthcare. His track record of building and growing a
commercial healthcare business and his experience of capital
markets will be invaluable as we continue to execute our strategy
and build a world leading innovative medical technology company
focused on neonatal intensive care."
Alan Olby, incoming Chief Financial Officer commented: "I am
delighted to be joining Inspiration Healthcare at this exciting
stage in the Group's development. The Group's world class design
and manufacturing expertise enables it to provide a broad range of
specialist, innovative products that address the critical needs
within the global neonatal market and I look forward to working to
accelerate the Group's growth strategy."
In accordance with Schedule 2 (g) of the AIM Rules for
Companies, Alan Musgrave Olby (aged 52 years) holds/has held the
following directorships/partnerships in the last five years:
Current directorships/partnerships Previous directorships/partnerships
(last five years)
None Acorus Therapeutics Limited
-----------------------------------
Aqtis Medical BV
Cocoon Medical Italy SRL
Cocoon Medical Colombia SAS
Cocoon Medical Hong Kong Limited
Cocoon Medical International
EOOD
Cocoon Medical USA LLC
High Technology Products SL
IS Pharma Limited
IS Pharmaceuticals Limited
Sinclair Aesthetics De Mexico
S.A. De C.V.
Sinclair Chile SPA
Sinclair Korea Limited
Silhouette Lift SL
Sinclair France SAS
Sinclair Holding BV
Sinclair Holdings Iberia SL
Sinclair Netherlands IP BV
Sinclair Pharma GmbH
Sinclair Pharma Holdings Limited
Sinclair Pharma Limited
Sinclair Pharma Man Co Limited
Sinclair Pharma Management
Limited
Sinclair Pharmaceutical Espana
SL.
Sinclair Pharmaceuticals (Asia
Pacific) Pte. Ltd
Sinclair Pharmaceuticals Limited
Sinclair Pharmaceuticals Limited
Singapore Branch
Sinclair Pharmaceuticals Limited
Sp. z o.o.
Sinclair Lifesciences India
Private Ltd
Speciality European Pharma
International AG
Viora Inc.
Viora Canada Ltd
Viora Ltd
Alan Olby resigned as a director of Speciality European Pharma
International AG in the 12 months prior to the company going into
liquidation on 29 November 2018.
Other than the award of share options, as noted below, Alan Olby
has no existing interest in the ordinary shares of the Company.
There are no further disclosures to be made under Schedule 2(g)
of the AIM Rules for Companies.
Grant of Options
Alan Olby has been granted a total of 222,222 nil cost options
over ordinary shares of 10 pence each in the capital of the Company
("Options") under the Inspiration Healthcare Group Long Term
Incentive Plan as detailed below.
The Options are exercisable at nil cost and are subject to
continuous employment with the Company for a period of three years
ending on 11 June 2026.
Inspiration Healthcare Group Tel: +44 (0)330 175 0000
plc
Neil Campbell, Chief Executive
Officer
Liberum (Nominated Adviser & Tel: +44 (0)20 3100 2000
Broker)
Phil Walker, Richard Lindley,
William Hall, Will King
Walbrook PR Ltd (Media and Investor Tel: +44 (0)20 7933 8780
Relations)
Anna Dunphy/Stephanie Cuthbert
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name 1. Alan Olby
------------------ -----------------------------------------------
2 Reason for the notification
-------------------------------------------------------------------
a) Position/status 1. PDMR (CFO)
------------------ -----------------------------------------------
b) Initial Initial
notification
/Amendment
------------------ -----------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------
a) Name Inspiration Healthcare Group plc
------------------ -----------------------------------------------
b) LEI 213800GKFT3ENAPMDL15
------------------ -----------------------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-------------------------------------------------------------------
a) Description Options over Ordinary Shares of 10p each
of the in the capital of the Company
financial ISIN: GB00BXDZL105
instrument,
type of
instrument
Identification
code
------------------ -----------------------------------------------
b) Nature Grant of Options under the Long Term Incentive
of the Plan
transaction
------------------ -----------------------------------------------
c) Price(s) Price(s) Volume(s)
and volume(s) 1. Nil 1. 222,222
------------------ -----------------------------------------------
d) Aggregated
information
-Aggregated N/A - single transaction
volume
- Price
------------------ -----------------------------------------------
e) Date of 12 June 2023
the transaction
------------------ -----------------------------------------------
f) Place of Outside of a trading venue
the transaction
------------------ -----------------------------------------------
About Inspiration Healthcare
Inspiration Healthcare (AIM: IHC) is a global provider of
medical technology for use in neonatal intensive care &
operating theatres. The Company provides high quality innovative
products to patients around the world which help to improve patient
outcomes and it actively invests in innovative product
opportunities and disruptive technologies.
The Company has key own brand products that can be used within
the first days of life to help premature and sick babies; helping
resuscitation and stabilisation in the first moments of life
through to preventing brain damage and both invasive and
non-invasive respiratory support in terms of capital equipment and
disposable medical devices. Additionally, the Company has its own
range of products for maintaining normothermia pre, during and
post-surgery.
Since September 2019, the Company has acquired Vio Holdings a
designer, manufacturer and supplier of single use respiratory
products and sterile medical consumables and S.L.E., a leading
designer, manufacturer and global provider of neonatal ventilation
products. The Group generates approximately 58% of its revenues
from export markets and more than half of its revenues come from
its own-branded products.
With product availability actively promoted to over 80 countries
through a distribution network, Inspiration Healthcare's success
has been built on continuous innovation, excellent customer service
and an inherent commitment to improving patient outcomes, working
in close collaboration with key opinion leaders across the
globe.
In the UK and Ireland, the Group has direct sales teams selling
Group Branded and complementary products from third parties, with
an additional range of home healthcare products. This is supported
by Technical Support for planned preventative maintenance and
emergency assistance.
The Group operates from various sites in the UK for R&D,
Marketing and operations with manufacturing based in Croydon (south
London) and Hailsham (East Sussex). The Group's Head Office is
located in Crawley, a short distance from London's Gatwick
Airport.
Further information on Inspiration Healthcare can be found at
www.inspirationhealthcaregroup.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BOASFWFSFEDSEFM
(END) Dow Jones Newswires
June 12, 2023 02:00 ET (06:00 GMT)
Inspiration Healthcare (LSE:IHC)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Inspiration Healthcare (LSE:IHC)
Gráfica de Acción Histórica
De May 2023 a May 2024
